Literature DB >> 9029639

A survey of the newborn populations in Belgium, Germany, Poland, Czech Republic, Hungary, Bulgaria, Spain, Turkey, and Japan for the G985 variant allele with haplotype analysis at the medium chain Acyl-CoA dehydrogenase gene locus: clinical and evolutionary consideration.

K Tanaka1, N Gregersen, A Ribes, J Kim, S Kølvraa, V Winter, H Eiberg, G Martinez, T Deufel, B Leifert, R Santer, B François, E Pronicka, A László, S Kmoch, I Kremensky, L Kalaydjicva, I Ozalp, M Ito.   

Abstract

Medium chain acyl-CoA dehydrogenase (MCAD) deficiency is an inborn error of fatty acid metabolism. It is one of the most frequent genetic metabolic disorders among Caucasian children. The G985 allele represented 90% of all the variant alleles of the MCAD gene in an extensive series of retrospective studies. To study the distribution of the G985 allele, newborn blood samples from the following countries were tested; 3000 from Germany (1/116). 1000 each from Belgium (1/77). Poland (1/98), Czech Republic (1/240). Hungary (1/168), Bulgaria (1/91), Spain (1/141). Turkey (1/216), and 500 from Japan (none). The frequency is shown in parentheses. The haplotype of G985 alleles in 1 homozygote and 57 heterozygote samples were then analyzed using two intragenic MCAD gene polymorphisms (Iaq1 and GT-repeat). The result indicated that only 1 of the 10 known haplotypes was associated with the G985 mutation, suggesting that G985 was derived originally from a single ancestral source. We made a compilation of the G985 frequencies in these countries and those in nine other European countries studied previously. The G985 distribution was high in the area stretching from Russia to Bulgaria in the east and in all northern countries in western and middle Europe, but low in the southern part of western and middle Europe. The incidence among ethnic Basques appeared to be low. This distribution pattern and the fact that all G985 alleles belong to a single haplotype suggest that G985 mutation occurred later than the delta F508 mutation of the CFTR, possibly in the neolithic or in a later period, and was brought into Europe by IndoEuropean-speaking people. The panEuropean distribution of the G985 allele, including Slavic countries from which patients with MCAD deficiency have rarely been detected, indicates the importance of raising the level of awareness of this disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029639     DOI: 10.1203/00006450-199702000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  13 in total

1.  Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency.

Authors:  H H Huidekoper; J Schneider; T Westphal; F M Vaz; M Duran; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2006-08-02       Impact factor: 4.982

Review 2.  Newborn screening: After the thrill is gone.

Authors:  Jerry Vockley
Journal:  Mol Genet Metab       Date:  2007-07-02       Impact factor: 4.797

3.  Normal rates of whole-body fat oxidation and gluconeogenesis after overnight fasting and moderate-intensity exercise in patients with medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  Hidde H Huidekoper; Mariëtte T Ackermans; René Koopman; Luc J C van Loon; Hans P Sauerwein; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

4.  Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies.

Authors:  K Carpenter; V Wiley; K G Sim; D Heath; B Wilcken
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

5.  Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK.

Authors:  R J Pollitt; J V Leonard
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

6.  Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  B S Andresen; S Olpin; B J Poorthuis; H R Scholte; C Vianey-Saban; R Wanders; L Ijlst; A Morris; M Pourfarzam; K Bartlett; E R Baumgartner; J B deKlerk; L D Schroeder; T J Corydon; H Lund; V Winter; P Bross; L Bolund; N Gregersen
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

7.  A novel mutation of the ACADM gene (c.145C>G) associated with the common c.985A>G mutation on the other ACADM allele causes mild MCAD deficiency: a case report.

Authors:  Anne-Frédérique Dessein; Monique Fontaine; Brage S Andresen; Niels Gregersen; Michèle Brivet; Daniel Rabier; Silvia Napuri-Gouel; Dries Dobbelaere; Karine Mention-Mulliez; Annie Martin-Ponthieu; Gilbert Briand; David S Millington; Christine Vianey-Saban; Ronald J A Wanders; Joseph Vamecq
Journal:  Orphanet J Rare Dis       Date:  2010-10-05       Impact factor: 4.123

8.  Functional studies of 18 heterologously expressed medium-chain acyl-CoA dehydrogenase (MCAD) variants.

Authors:  Kira-Lee Koster; Marga Sturm; Diran Herebian; Sander H J Smits; Ute Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2014-06-26       Impact factor: 4.982

9.  Adult presentation of MCAD deficiency revealed by coma and severe arrythmias.

Authors:  F Feillet; G Steinmann; C Vianey-Saban; C de Chillou; N Sadoul; E Lefebvre; M Vidailhet; P E Bollaert
Journal:  Intensive Care Med       Date:  2003-08-01       Impact factor: 17.440

10.  Birth Prevalence of Fatty Acid β-Oxidation Disorders in Iberia.

Authors:  Hugo Rocha; Daisy Castiñeiras; Carmen Delgado; José Egea; Raquel Yahyaoui; Yolanda González; Manuel Conde; Inmaculada González; Inmaculada Rueda; Luis Rello; Laura Vilarinho; José Cocho
Journal:  JIMD Rep       Date:  2014-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.